1 Safe-and-Steady Stock with Solid Fundamentals and 2 That Underwhelm

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Luckily for you, StockStory helps you navigate which companies are truly worth holding. That said, here is one low-volatility stock that could offer consistent gains and two that may not deliver the returns you need.

Two Stocks to Sell:

Strategy (MSTR)

Rolling One-Year Beta: 0.86

Once a traditional business intelligence software provider, Strategy (NASDAQ:MSTR) develops AI-powered enterprise analytics software while also functioning as a major corporate holder of Bitcoin cryptocurrency.

Why Do We Steer Clear of MSTR?

1. MicroStrategy’s core analytics software has been eclipsed by its all-in Bitcoin strategy, leaving product innovation and enterprise deals starved for attention
2. The company’s debt-financed Bitcoin buying ties shareholder fortunes to crypto swings and interest rates, amplifying downside risk and uncertainty
3. On the bright side, its vast Bitcoin treasury gives Executive Chairman Michael Saylor a unique springboard to capture crypto upside and court investors seeking leveraged exposure to digital assets

Strategy’s stock price of $135.17 implies a valuation ratio of 63.7x forward price-to-sales. Read our free research report to see why you should think twice about including MSTR in your portfolio.

Henry Schein (HSIC)

Rolling One-Year Beta: 0.38

With a vast inventory of over 300,000 products stocked in distribution centers spanning more than 5.3 million square feet worldwide, Henry Schein (NASDAQ:HSIC) is a global distributor of healthcare products and services primarily to dental practices, medical offices, and other healthcare facilities.

Why Does HSIC Worry Us?

1. Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion
2. 2.8 percentage point decline in its free cash flow margin over the last five years reflects the company’s increased investments to defend its market position
3. Eroding returns on capital suggest its historical profit centers are aging

At $79.71 per share, Henry Schein trades at 14.8x forward P/E. Check out our free in-depth research report to learn more about why HSIC doesn’t pass our bar.

One Stock to Watch:

AMETEK (AME)

Rolling One-Year Beta: 0.86

Started from its humble beginnings in motor repair, AMETEK (NYSE:AME) manufactures electronic devices used in industries like aerospace, power, and healthcare.

Why Does AME Stand Out?

1. Solid 10.3% annual revenue growth over the last five years indicates its offering’s solve complex business issues
2. Healthy operating margin of 25.1% shows it’s a well-run company with efficient processes, and it turbocharged its profits by achieving some fixed cost leverage
3. Robust free cash flow margin of 21.5% gives it many options for capital deployment, and its recently improved profitability means it has even more resources to invest or distribute

AMETEK is trading at $232.86 per share, or 28.6x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free.

Stocks We Like Even More

If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.

Don’t wait for the next volatility shock. Check out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.